Glutathione Drip Therapy
Also known as: Gluta drip · IV gluta · Intravenous glutathione therapy · Skin lightening drip
Definition
Glutathione Drip Therapy (commonly known in the Philippines as gluta drip) is the intravenous administration of glutathione, often formulated with high doses of Vitamin C and other antioxidants, marketed primarily for cosmetic skin whitening and anti-aging. While highly popular in Philippine aesthetic clinics, beauty salons, and home-service wellness setups, the Food and Drug Administration (FDA) of the Philippines and the Department of Health (DOH) have issued strict public warnings against the practice, stating that no injectable glutathione products are approved for skin lightening and that the therapy carries severe systemic health risks. (PNA)
Identities
| Source Type | Identity |
|---|---|
| Wikipedia | Glutathione |
| Wikidata | Q415303 |
| DBpedia | Glutathione |
| ProductOntology | N/A |
| Wiktionary | glutathione |
| Library of Congress Subject Headings (LCSH) | Dermatologic agents — Toxicology — Philippines |
| MeSH | Glutathione |
| NCBI Taxonomy | N/A |
| AGROVOC | N/A |
| Google Scholar | glutathione drip skin whitening FDA warning Philippines |
| ConceptNet | glutathione |
| OpenCyc | N/A |
Also Known As
- Gluta drip
- IV gluta
- Intravenous glutathione therapy
- Skin lightening drip
Examples and Analogies
- Chemotherapy Adjunct (FDA-Approved Use): The clinical administration of injectable glutathione to reduce cisplatin-induced neurotoxicity in cancer patients, which remains the only FDA-approved medical indication for the drug in the Philippines. (PNA)
- Aesthetic Clinic Infusions (Off-Label Use): Salons and skin clinics administering high-dose glutathione drips to healthy individuals for the side effect of skin lightening, which is achieved by temporarily inhibiting the melanin-producing enzyme tyrosinase.
Usage Scenarios
1. Cosmetic Skin Lightening
A client visits a cosmetic clinic in Metro Manila to receive weekly glutathione infusions combined with Vitamin C in hopes of achieving a lighter skin tone. (Inquirer)
2. Regulatory Enforcement and Advisories
The FDA Philippines issues a public warning advisory after discovering unregistered IV glutathione vials and infusion kits being sold on major e-commerce platforms. (FDA Philippines)
Strategies
- Verify the registration status of any injectable product using the FDA Philippines verification portal before administration.
- Consult a board-certified dermatologist for evidence-based skin lightening alternatives, such as topical agents with proven safety profiles.
- Report unlicensed clinics or spas offering IV drip infusions without licensed medical supervision to the DOH or local health department.
Security and Safety Measures
- Do not undergo glutathione drip infusions in non-sterile environments or salons, as it carries risks of severe blood-borne infections (such as HIV and Hepatitis B) and air embolisms.
- Never purchase injectable glutathione vials from unauthorized online resellers or informal retail markets, which are frequently counterfeit, contaminated, or sub-potent.
- Monitor for serious adverse symptoms, such as severe skin rashes (Stevens-Johnson syndrome), thyroid dysfunction, and signs of kidney injury (e.g., blood in urine or decreased urination). (PNA)
Historical Context
The beauty industry in the Philippines has long emphasized fair skin, driving a massive market for skin-lightening products. Glutathione, a naturally occurring tripeptide antioxidant, gained prominence in the 2000s through oral supplements and soaps. By the 2010s, intravenous “gluta drips” became a trend, popularized by celebrity endorsements and social media influencers. In response to rising reports of adverse events, the FDA Philippines issued multiple public warnings (such as FDA Advisory No. 2019-181) reiterating that no injectable glutathione is approved for cosmetic skin whitening. (Inquirer) (FDA Philippines)
Challenges and Controversies
No Approved Cosmetic Indication
The FDA has only approved injectable glutathione for chemotherapy adjunct use; using it for skin whitening is an off-label practice with no clinical trials validating long-term safety, correct cosmetic dosing, or efficacy.
Severe Toxic Side Effects
Clinical reports have linked high-dose IV glutathione to kidney failure, liver toxicity, thyroid dysfunction, and life-threatening Stevens-Johnson syndrome. When paired with high-dose intravenous Vitamin C, the therapy also increases the risk of kidney stones. (PNA)
Regulatory Enforcement Gap
The DOH and FDA regulate product registration, but have limited authority to stop licensed physicians from prescribing approved drugs “off-label” in private clinics, shifting the regulatory burden to professional licensing boards like the Professional Regulation Commission (PRC).